Clinical Trial Update: Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study evaluating brain interstitium temozolomide concentration before and after regadenoson administration; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Brain Barrier Defect

Drugs mentioned

• Regadenoson (Regadenoson)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Blood Brain Barrier Defect | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2018-11-20